Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma
✍ Scribed by Francesca Perandin; Elisabetta Cariani; Caterina Patrizia Pollara; Nino Manca
- Book ID
- 115005632
- Publisher
- BioMed Central
- Year
- 2007
- Tongue
- English
- Weight
- 268 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1471-2180
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epstein‐Barr virus (EBV) reactivation is more likely to occur in immunocompromised patients with subsequent higher susceptibility to EBV‐associated lymphoproliferations. In contrast to transplant recipients, limited data are available concerning the EBV load in HIV‐infected patients, wi
## Abstract ## BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration